Global Oral Hypoglycemic Agents (OHAs) Market Research Report 2023

Report ID: 1993423 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Oral Hypoglycemic Agents (OHAs) Market Overview
    1.1 Product Overview and Scope of Oral Hypoglycemic Agents (OHAs)
    1.2 Oral Hypoglycemic Agents (OHAs) Segment by Type
        1.2.1 Global Oral Hypoglycemic Agents (OHAs) Market Value Comparison by Type (2023-2029)
        1.2.2 Sulfonylureas
        1.2.3 Metformin
        1.2.4 Thiazolidinediones
        1.2.5 Alpha-Glucosidase Inhibitors
    1.3 Oral Hypoglycemic Agents (OHAs) Segment by Application
        1.3.1 Global Oral Hypoglycemic Agents (OHAs) Market Value by Application: (2023-2029)
        1.3.2 Type 2 Diabetes Mellitus
        1.3.3 Type 1 Diabetes Mellitus
    1.4 Global Oral Hypoglycemic Agents (OHAs) Market Size Estimates and Forecasts
        1.4.1 Global Oral Hypoglycemic Agents (OHAs) Revenue 2018-2029
        1.4.2 Global Oral Hypoglycemic Agents (OHAs) Sales 2018-2029
        1.4.3 Global Oral Hypoglycemic Agents (OHAs) Market Average Price (2018-2029)
    1.5 Assumptions and Limitations
2 Oral Hypoglycemic Agents (OHAs) Market Competition by Manufacturers
    2.1 Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Oral Hypoglycemic Agents (OHAs) Average Price by Manufacturers (2018-2023)
    2.4 Global Oral Hypoglycemic Agents (OHAs) Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Oral Hypoglycemic Agents (OHAs), Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Oral Hypoglycemic Agents (OHAs), Product Type & Application
    2.7 Oral Hypoglycemic Agents (OHAs) Market Competitive Situation and Trends
        2.7.1 Oral Hypoglycemic Agents (OHAs) Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Oral Hypoglycemic Agents (OHAs) Players Market Share by Revenue
        2.7.3 Global Oral Hypoglycemic Agents (OHAs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Hypoglycemic Agents (OHAs) Retrospective Market Scenario by Region
    3.1 Global Oral Hypoglycemic Agents (OHAs) Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Oral Hypoglycemic Agents (OHAs) Global Oral Hypoglycemic Agents (OHAs) Sales by Region: 2018-2029
        3.2.1 Global Oral Hypoglycemic Agents (OHAs) Sales by Region: 2018-2023
        3.2.2 Global Oral Hypoglycemic Agents (OHAs) Sales by Region: 2024-2029
    3.3 Global Oral Hypoglycemic Agents (OHAs) Global Oral Hypoglycemic Agents (OHAs) Revenue by Region: 2018-2029
        3.3.1 Global Oral Hypoglycemic Agents (OHAs) Revenue by Region: 2018-2023
        3.3.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Region: 2024-2029
    3.4 North America Oral Hypoglycemic Agents (OHAs) Market Facts & Figures by Country
        3.4.1 North America Oral Hypoglycemic Agents (OHAs) Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Oral Hypoglycemic Agents (OHAs) Sales by Country (2018-2029)
        3.4.3 North America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Oral Hypoglycemic Agents (OHAs) Market Facts & Figures by Country
        3.5.1 Europe Oral Hypoglycemic Agents (OHAs) Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Oral Hypoglycemic Agents (OHAs) Sales by Country (2018-2029)
        3.5.3 Europe Oral Hypoglycemic Agents (OHAs) Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Oral Hypoglycemic Agents (OHAs) Market Facts & Figures by Country
        3.6.1 Asia Pacific Oral Hypoglycemic Agents (OHAs) Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Oral Hypoglycemic Agents (OHAs) Sales by Country (2018-2029)
        3.6.3 Asia Pacific Oral Hypoglycemic Agents (OHAs) Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Oral Hypoglycemic Agents (OHAs) Market Facts & Figures by Country
        3.7.1 Latin America Oral Hypoglycemic Agents (OHAs) Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Oral Hypoglycemic Agents (OHAs) Sales by Country (2018-2029)
        3.7.3 Latin America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Oral Hypoglycemic Agents (OHAs) Market Facts & Figures by Country
        3.8.1 Middle East and Africa Oral Hypoglycemic Agents (OHAs) Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Oral Hypoglycemic Agents (OHAs) Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Oral Hypoglycemic Agents (OHAs) Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE
4 Segment by Type
    4.1 Global Oral Hypoglycemic Agents (OHAs) Sales by Type (2018-2029)
        4.1.1 Global Oral Hypoglycemic Agents (OHAs) Sales by Type (2018-2023)
        4.1.2 Global Oral Hypoglycemic Agents (OHAs) Sales by Type (2024-2029)
        4.1.3 Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Type (2018-2029)
    4.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Type (2018-2029)
        4.2.1 Global Oral Hypoglycemic Agents (OHAs) Revenue by Type (2018-2023)
        4.2.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Type (2024-2029)
        4.2.3 Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Type (2018-2029)
    4.3 Global Oral Hypoglycemic Agents (OHAs) Price by Type (2018-2029)
5 Segment by Application
    5.1 Global Oral Hypoglycemic Agents (OHAs) Sales by Application (2018-2029)
        5.1.1 Global Oral Hypoglycemic Agents (OHAs) Sales by Application (2018-2023)
        5.1.2 Global Oral Hypoglycemic Agents (OHAs) Sales by Application (2024-2029)
        5.1.3 Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application (2018-2029)
    5.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Application (2018-2029)
        5.2.1 Global Oral Hypoglycemic Agents (OHAs) Revenue by Application (2018-2023)
        5.2.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Application (2024-2029)
        5.2.3 Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Application (2018-2029)
    5.3 Global Oral Hypoglycemic Agents (OHAs) Price by Application (2018-2029)
6 Key Companies Profiled
    6.1 Pfizer
        6.1.1 Pfizer Corporation Information
        6.1.2 Pfizer Description and Business Overview
        6.1.3 Pfizer Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Pfizer Oral Hypoglycemic Agents (OHAs) Product Portfolio
        6.1.5 Pfizer Recent Developments/Updates
    6.2 GlaxoSmithKline
        6.2.1 GlaxoSmithKline Corporation Information
        6.2.2 GlaxoSmithKline Description and Business Overview
        6.2.3 GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Product Portfolio
        6.2.5 GlaxoSmithKline Recent Developments/Updates
    6.3 Bayer
        6.3.1 Bayer Corporation Information
        6.3.2 Bayer Description and Business Overview
        6.3.3 Bayer Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Bayer Oral Hypoglycemic Agents (OHAs) Product Portfolio
        6.3.5 Bayer Recent Developments/Updates
    6.4 Bristol-Myers Squibb
        6.4.1 Bristol-Myers Squibb Corporation Information
        6.4.2 Bristol-Myers Squibb Description and Business Overview
        6.4.3 Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Product Portfolio
        6.4.5 Bristol-Myers Squibb Recent Developments/Updates
    6.5 Novonordisk
        6.5.1 Novonordisk Corporation Information
        6.5.2 Novonordisk Description and Business Overview
        6.5.3 Novonordisk Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Novonordisk Oral Hypoglycemic Agents (OHAs) Product Portfolio
        6.5.5 Novonordisk Recent Developments/Updates
    6.6 Sanofi-Aventis
        6.6.1 Sanofi-Aventis Corporation Information
        6.6.2 Sanofi-Aventis Description and Business Overview
        6.6.3 Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Product Portfolio
        6.6.5 Sanofi-Aventis Recent Developments/Updates
    6.7 Servier
        6.6.1 Servier Corporation Information
        6.6.2 Servier Description and Business Overview
        6.6.3 Servier Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Servier Oral Hypoglycemic Agents (OHAs) Product Portfolio
        6.7.5 Servier Recent Developments/Updates
    6.8 Huadong Medicine
        6.8.1 Huadong Medicine Corporation Information
        6.8.2 Huadong Medicine Description and Business Overview
        6.8.3 Huadong Medicine Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Huadong Medicine Oral Hypoglycemic Agents (OHAs) Product Portfolio
        6.8.5 Huadong Medicine Recent Developments/Updates
    6.9 Wanbang Biopharmaceuticals
        6.9.1 Wanbang Biopharmaceuticals Corporation Information
        6.9.2 Wanbang Biopharmaceuticals Description and Business Overview
        6.9.3 Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Product Portfolio
        6.9.5 Wanbang Biopharmaceuticals Recent Developments/Updates
    6.10 Double-Crane Pharmaceutical
        6.10.1 Double-Crane Pharmaceutical Corporation Information
        6.10.2 Double-Crane Pharmaceutical Description and Business Overview
        6.10.3 Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product Portfolio
        6.10.5 Double-Crane Pharmaceutical Recent Developments/Updates
    6.11 Guangzhou Pharmaceutical
        6.11.1 Guangzhou Pharmaceutical Corporation Information
        6.11.2 Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Description and Business Overview
        6.11.3 Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2018-2023)
        6.11.4 Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product Portfolio
        6.11.5 Guangzhou Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
    7.1 Oral Hypoglycemic Agents (OHAs) Industry Chain Analysis
    7.2 Oral Hypoglycemic Agents (OHAs) Key Raw Materials
       7.2.1 Key Raw Materials
       7.2.2 Raw Materials Key Suppliers
    7.3 Oral Hypoglycemic Agents (OHAs) Production Mode & Process
    7.4 Oral Hypoglycemic Agents (OHAs) Sales and Marketing
        7.4.1 Oral Hypoglycemic Agents (OHAs) Sales Channels
        7.4.2 Oral Hypoglycemic Agents (OHAs) Distributors
    7.5 Oral Hypoglycemic Agents (OHAs) Customers
8 Oral Hypoglycemic Agents (OHAs) Market Dynamics
    8.1 Oral Hypoglycemic Agents (OHAs) Industry Trends
    8.2 Oral Hypoglycemic Agents (OHAs) Market Drivers
    8.3 Oral Hypoglycemic Agents (OHAs) Market Challenges
    8.4 Oral Hypoglycemic Agents (OHAs) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer
List of Tables
    Table 1. Global Oral Hypoglycemic Agents (OHAs) Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Oral Hypoglycemic Agents (OHAs) Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Oral Hypoglycemic Agents (OHAs) Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Oral Hypoglycemic Agents (OHAs) Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Oral Hypoglycemic Agents (OHAs) Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Oral Hypoglycemic Agents (OHAs) Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Oral Hypoglycemic Agents (OHAs) Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Oral Hypoglycemic Agents (OHAs), Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Oral Hypoglycemic Agents (OHAs), Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Oral Hypoglycemic Agents (OHAs), Product Type & Application
    Table 12. Global Key Manufacturers of Oral Hypoglycemic Agents (OHAs), Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Oral Hypoglycemic Agents (OHAs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Hypoglycemic Agents (OHAs) as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Oral Hypoglycemic Agents (OHAs) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Oral Hypoglycemic Agents (OHAs) Sales by Region (2018-2023) & (K Units)
    Table 18. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Region (2018-2023)
    Table 19. Global Oral Hypoglycemic Agents (OHAs) Sales by Region (2024-2029) & (K Units)
    Table 20. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Region (2024-2029)
    Table 21. Global Oral Hypoglycemic Agents (OHAs) Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Region (2018-2023)
    Table 23. Global Oral Hypoglycemic Agents (OHAs) Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Region (2024-2029)
    Table 25. North America Oral Hypoglycemic Agents (OHAs) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Oral Hypoglycemic Agents (OHAs) Sales by Country (2018-2023) & (K Units)
    Table 27. North America Oral Hypoglycemic Agents (OHAs) Sales by Country (2024-2029) & (K Units)
    Table 28. North America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Oral Hypoglycemic Agents (OHAs) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Oral Hypoglycemic Agents (OHAs) Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Oral Hypoglycemic Agents (OHAs) Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Oral Hypoglycemic Agents (OHAs) Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Oral Hypoglycemic Agents (OHAs) Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Oral Hypoglycemic Agents (OHAs) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Oral Hypoglycemic Agents (OHAs) Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Oral Hypoglycemic Agents (OHAs) Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Oral Hypoglycemic Agents (OHAs) Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Oral Hypoglycemic Agents (OHAs) Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Oral Hypoglycemic Agents (OHAs) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Oral Hypoglycemic Agents (OHAs) Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Oral Hypoglycemic Agents (OHAs) Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Oral Hypoglycemic Agents (OHAs) Sales (K Units) by Type (2018-2023)
    Table 51. Global Oral Hypoglycemic Agents (OHAs) Sales (K Units) by Type (2024-2029)
    Table 52. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Type (2018-2023)
    Table 53. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Type (2024-2029)
    Table 54. Global Oral Hypoglycemic Agents (OHAs) Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Oral Hypoglycemic Agents (OHAs) Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Type (2018-2023)
    Table 57. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Type (2024-2029)
    Table 58. Global Oral Hypoglycemic Agents (OHAs) Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Oral Hypoglycemic Agents (OHAs) Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Oral Hypoglycemic Agents (OHAs) Sales (K Units) by Application (2018-2023)
    Table 61. Global Oral Hypoglycemic Agents (OHAs) Sales (K Units) by Application (2024-2029)
    Table 62. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application (2018-2023)
    Table 63. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application (2024-2029)
    Table 64. Global Oral Hypoglycemic Agents (OHAs) Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Oral Hypoglycemic Agents (OHAs) Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Application (2018-2023)
    Table 67. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Application (2024-2029)
    Table 68. Global Oral Hypoglycemic Agents (OHAs) Price (USD/Unit) by Application (2018-2023)
    Table 69. Global Oral Hypoglycemic Agents (OHAs) Price (USD/Unit) by Application (2024-2029)
    Table 70. Pfizer Corporation Information
    Table 71. Pfizer Description and Business Overview
    Table 72. Pfizer Oral Hypoglycemic Agents (OHAs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Pfizer Oral Hypoglycemic Agents (OHAs) Product
    Table 74. Pfizer Recent Developments/Updates
    Table 75. GlaxoSmithKline Corporation Information
    Table 76. GlaxoSmithKline Description and Business Overview
    Table 77. GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Product
    Table 79. GlaxoSmithKline Recent Developments/Updates
    Table 80. Bayer Corporation Information
    Table 81. Bayer Description and Business Overview
    Table 82. Bayer Oral Hypoglycemic Agents (OHAs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Bayer Oral Hypoglycemic Agents (OHAs) Product
    Table 84. Bayer Recent Developments/Updates
    Table 85. Bristol-Myers Squibb Corporation Information
    Table 86. Bristol-Myers Squibb Description and Business Overview
    Table 87. Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Product
    Table 89. Bristol-Myers Squibb Recent Developments/Updates
    Table 90. Novonordisk Corporation Information
    Table 91. Novonordisk Description and Business Overview
    Table 92. Novonordisk Oral Hypoglycemic Agents (OHAs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Novonordisk Oral Hypoglycemic Agents (OHAs) Product
    Table 94. Novonordisk Recent Developments/Updates
    Table 95. Sanofi-Aventis Corporation Information
    Table 96. Sanofi-Aventis Description and Business Overview
    Table 97. Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Product
    Table 99. Sanofi-Aventis Recent Developments/Updates
    Table 100. Servier Corporation Information
    Table 101. Servier Description and Business Overview
    Table 102. Servier Oral Hypoglycemic Agents (OHAs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. Servier Oral Hypoglycemic Agents (OHAs) Product
    Table 104. Servier Recent Developments/Updates
    Table 105. Huadong Medicine Corporation Information
    Table 106. Huadong Medicine Description and Business Overview
    Table 107. Huadong Medicine Oral Hypoglycemic Agents (OHAs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. Huadong Medicine Oral Hypoglycemic Agents (OHAs) Product
    Table 109. Huadong Medicine Recent Developments/Updates
    Table 110. Wanbang Biopharmaceuticals Corporation Information
    Table 111. Wanbang Biopharmaceuticals Description and Business Overview
    Table 112. Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Product
    Table 114. Wanbang Biopharmaceuticals Recent Developments/Updates
    Table 115. Double-Crane Pharmaceutical Corporation Information
    Table 116. Double-Crane Pharmaceutical Description and Business Overview
    Table 117. Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 118. Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product
    Table 119. Double-Crane Pharmaceutical Recent Developments/Updates
    Table 120. Guangzhou Pharmaceutical Corporation Information
    Table 121. Guangzhou Pharmaceutical Description and Business Overview
    Table 122. Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 123. Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product
    Table 124. Guangzhou Pharmaceutical Recent Developments/Updates
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Oral Hypoglycemic Agents (OHAs) Distributors List
    Table 128. Oral Hypoglycemic Agents (OHAs) Customers List
    Table 129. Oral Hypoglycemic Agents (OHAs) Market Trends
    Table 130. Oral Hypoglycemic Agents (OHAs) Market Drivers
    Table 131. Oral Hypoglycemic Agents (OHAs) Market Challenges
    Table 132. Oral Hypoglycemic Agents (OHAs) Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Oral Hypoglycemic Agents (OHAs)
    Figure 2. Global Oral Hypoglycemic Agents (OHAs) Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Oral Hypoglycemic Agents (OHAs) Market Share by Type in 2022 & 2029
    Figure 4. Sulfonylureas Product Picture
    Figure 5. Metformin Product Picture
    Figure 6. Thiazolidinediones Product Picture
    Figure 7. Alpha-Glucosidase Inhibitors Product Picture
    Figure 8. Global Oral Hypoglycemic Agents (OHAs) Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Oral Hypoglycemic Agents (OHAs) Market Share by Application in 2022 & 2029
    Figure 10. Type 2 Diabetes Mellitus
    Figure 11. Type 1 Diabetes Mellitus
    Figure 12. Global Oral Hypoglycemic Agents (OHAs) Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Oral Hypoglycemic Agents (OHAs) Market Size (2018-2029) & (US$ Million)
    Figure 14. Global Oral Hypoglycemic Agents (OHAs) Sales (2018-2029) & (K Units)
    Figure 15. Global Oral Hypoglycemic Agents (OHAs) Average Price (USD/Unit) & (2018-2029)
    Figure 16. Oral Hypoglycemic Agents (OHAs) Report Years Considered
    Figure 17. Oral Hypoglycemic Agents (OHAs) Sales Share by Manufacturers in 2022
    Figure 18. Global Oral Hypoglycemic Agents (OHAs) Revenue Share by Manufacturers in 2022
    Figure 19. The Global 5 and 10 Largest Oral Hypoglycemic Agents (OHAs) Players: Market Share by Revenue in 2022
    Figure 20. Oral Hypoglycemic Agents (OHAs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 21. Global Oral Hypoglycemic Agents (OHAs) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 22. North America Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country (2018-2029)
    Figure 23. North America Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country (2018-2029)
    Figure 24. U.S. Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Canada Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Europe Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country (2018-2029)
    Figure 27. Europe Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country (2018-2029)
    Figure 28. Germany Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. France Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. U.K. Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Italy Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Russia Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Asia Pacific Oral Hypoglycemic Agents (OHAs) Sales Market Share by Region (2018-2029)
    Figure 34. Asia Pacific Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Region (2018-2029)
    Figure 35. China Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Japan Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. South Korea Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. India Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Australia Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Taiwan Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Indonesia Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Thailand Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Malaysia Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Philippines Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Latin America Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country (2018-2029)
    Figure 46. Latin America Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country (2018-2029)
    Figure 47. Mexico Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Brazil Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Argentina Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country (2018-2029)
    Figure 51. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country (2018-2029)
    Figure 52. Turkey Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. UAE Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Global Sales Market Share of Oral Hypoglycemic Agents (OHAs) by Type (2018-2029)
    Figure 56. Global Revenue Market Share of Oral Hypoglycemic Agents (OHAs) by Type (2018-2029)
    Figure 57. Global Oral Hypoglycemic Agents (OHAs) Price (USD/Unit) by Type (2018-2029)
    Figure 58. Global Sales Market Share of Oral Hypoglycemic Agents (OHAs) by Application (2018-2029)
    Figure 59. Global Revenue Market Share of Oral Hypoglycemic Agents (OHAs) by Application (2018-2029)
    Figure 60. Global Oral Hypoglycemic Agents (OHAs) Price (USD/Unit) by Application (2018-2029)
    Figure 61. Oral Hypoglycemic Agents (OHAs) Value Chain
    Figure 62. Oral Hypoglycemic Agents (OHAs) Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
Novonordisk
Sanofi-Aventis
Servier
Huadong Medicine
Wanbang Biopharmaceuticals
Double-Crane Pharmaceutical
Guangzhou Pharmaceutical
Frequently Asked Questions
Oral Hypoglycemic Agents (OHAs) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oral Hypoglycemic Agents (OHAs) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oral Hypoglycemic Agents (OHAs) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports